Kieran O'Neill1, Nima Aghaeepour2, Jeremy Parker2, Donna Hogge2, Aly Karsan2, Bakul Dalal2, Ryan R Brinkman1. 1. Terry Fox Laboratory, BC Cancer Agency, Bioinformatics Graduate Program, University of British Columbia, Department of Hematopathology, Vancouver General Hospital and Faculty of Medical Genetics, University of British Columbia, Vancouver, Canada Terry Fox Laboratory, BC Cancer Agency, Bioinformatics Graduate Program, University of British Columbia, Department of Hematopathology, Vancouver General Hospital and Faculty of Medical Genetics, University of British Columbia, Vancouver, Canada. 2. Terry Fox Laboratory, BC Cancer Agency, Bioinformatics Graduate Program, University of British Columbia, Department of Hematopathology, Vancouver General Hospital and Faculty of Medical Genetics, University of British Columbia, Vancouver, Canada.
Abstract
MOTIVATION: Deep profiling the phenotypic landscape of tissues using high-throughput flow cytometry (FCM) can provide important new insights into the interplay of cells in both healthy and diseased tissue. But often, especially in clinical settings, the cytometer cannot measure all the desired markers in a single aliquot. In these cases, tissue is separated into independently analysed samples, leaving a need to electronically recombine these to increase dimensionality. Nearest-neighbour (NN) based imputation fulfils this need but can produce artificial subpopulations. Clustering-based NNs can reduce these, but requires prior domain knowledge to be able to parameterize the clustering, so is unsuited to discovery settings. RESULTS: We present flowBin, a parameterization-free method for combining multitube FCM data into a higher-dimensional form suitable for deep profiling and discovery. FlowBin allocates cells to bins defined by the common markers across tubes in a multitube experiment, then computes aggregate expression for each bin within each tube, to create a matrix of expression of all markers assayed in each tube. We show, using simulated multitube data, that flowType analysis of flowBin output reproduces the results of that same analysis on the original data for cell types of >10% abundance. We used flowBin in conjunction with classifiers to distinguish normal from cancerous cells. We used flowBin together with flowType and RchyOptimyx to profile the immunophenotypic landscape of NPM1-mutated acute myeloid leukemia, and present a series of novel cell types associated with that mutation.
MOTIVATION: Deep profiling the phenotypic landscape of tissues using high-throughput flow cytometry (FCM) can provide important new insights into the interplay of cells in both healthy and diseased tissue. But often, especially in clinical settings, the cytometer cannot measure all the desired markers in a single aliquot. In these cases, tissue is separated into independently analysed samples, leaving a need to electronically recombine these to increase dimensionality. Nearest-neighbour (NN) based imputation fulfils this need but can produce artificial subpopulations. Clustering-based NNs can reduce these, but requires prior domain knowledge to be able to parameterize the clustering, so is unsuited to discovery settings. RESULTS: We present flowBin, a parameterization-free method for combining multitube FCM data into a higher-dimensional form suitable for deep profiling and discovery. FlowBin allocates cells to bins defined by the common markers across tubes in a multitube experiment, then computes aggregate expression for each bin within each tube, to create a matrix of expression of all markers assayed in each tube. We show, using simulated multitube data, that flowType analysis of flowBin output reproduces the results of that same analysis on the original data for cell types of >10% abundance. We used flowBin in conjunction with classifiers to distinguish normal from cancerous cells. We used flowBin together with flowType and RchyOptimyx to profile the immunophenotypic landscape of NPM1-mutated acute myeloid leukemia, and present a series of novel cell types associated with that mutation.
Authors: Carlos Eduardo Pedreira; Elaine S Costa; M Elena Arroyo; Julia Almeida; Alberto Orfao Journal: IEEE Trans Biomed Eng Date: 2008-03 Impact factor: 4.538
Authors: Christian Thiede; Sina Koch; Eva Creutzig; Christine Steudel; Thomas Illmer; Markus Schaich; Gerhard Ehninger Journal: Blood Date: 2006-02-02 Impact factor: 22.113
Authors: Brent L Wood; Maria Arroz; David Barnett; Joseph DiGiuseppe; Bruce Greig; Steven J Kussick; Teri Oldaker; Mark Shenkin; Elizabeth Stone; Paul Wallace Journal: Cytometry B Clin Cytom Date: 2007 Impact factor: 3.058
Authors: Adrien Leite Pereira; Olivier Lambotte; Roger Le Grand; Antonio Cosma; Nicolas Tchitchek Journal: Bioinformatics Date: 2019-10-15 Impact factor: 6.937
Authors: Adrien Leite Pereira; Nicolas Tchitchek; Olivier Lambotte; Roger Le Grand; Antonio Cosma Journal: Front Immunol Date: 2019-08-06 Impact factor: 7.561
Authors: Tamim Abdelaal; Thomas Höllt; Vincent van Unen; Boudewijn P F Lelieveldt; Frits Koning; Marcel J T Reinders; Ahmed Mahfouz Journal: Bioinformatics Date: 2019-10-15 Impact factor: 6.937